Biosimilars for people with rheumatoid arthritis and ankylosing spondylitis work as well and are as safe as the original biologic, says review
Biosimilars of anti-TNF-α agents have comparable efficacy and safety profile for use in people with rheumatoid arthritis and ankylosing spondylitis as their original biologic, a team outlines in the Journal of Autoimmunity.
A type of E. coli bacteria found in people with Crohn’s disease can trigger inflammation associated with spondyloarthritis, according to research in Science Translational Medicine. Continue reading
Commonly used non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin and ibuprofen may have little benefit in terms of reducing back pain, and potentially put people at risk of side effects, says research in the Annals of the Rheumatic Diseases.
Common pain relievers – NSAIDs – may increase heart attack risk when people have severe colds and flu
Widely used pain relievers may increase the risk of heart attack when used during respiratory infections, experts warn in the Journal of Infectious Diseases.
Healthcare professionals and patients should be careful when prescribing or taking non-steroidal anti-inflammatory drugs (NSAIDs) to ease symptoms of acute respiratory infections. Continue reading
People with joint conditions in three areas of the UK could soon find it harder to get access to knee and hip replacement surgery because of changes in eligibility criteria, reports the Health Service Journal.